Jefferies rates 5 CRDMO stocks ‘Buy’ with up to 20% upside potential
- Posted on August 27, 2026
- By Financial Express
- 0 Views
- 1 min read
In brief
Generating AI summary…
Jefferies rates 5 CRDMO stocks ‘Buy’ with up to 20% upside potential
Jefferies is turning bullish on India’s CRDMO space after a strong quarter. Sai Life Sciences and Divi’s Laboratories remain top picks, while Gland Pharma joins the Buy list and Anthem Biosciences offers the highest potential upside.
